US FDA approves Abbott's XIENCE stent to treat blood thinner course for high bleeding risk patients

Press/Media

Period	3 Jul 2021

Media coverage

Title US FDA approves Abbott's XIENCE stent to treat blood thinner course for high bleeding risk patients
Media name/outlet PharmaBiz
Country/Territory India
Date 3/07/21
Persons Roxana Mehran,

Title	US FDA approves Abbott's XIENCE stent to treat blood thinner course for high bleeding risk patients
Media name/outlet	PharmaBiz
Country/Territory	India
Date	3/07/21
Persons	Roxana Mehran,